Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis modelsThomas Sorz, Thomas Reiberger, Katharina Regnat et al.|Scientific Reports|2025Cited by 4
WED-122-YI The soluble guanylate cyclase pathway is dysregulated in rodent models of cirrhosis and portal hypertensionThomas Sorz‐Nechay, Thomas Reiberger, Ksenia Brusilovskaya et al.|Journal of Hepatology|2024Cited by 0
WED-125 Differential regulation of soluble guanylate cyclase signaling during liver fibrosis regressionThomas Sorz‐Nechay, Thomas Reiberger, Ksenia Brusilovskaya et al.|Journal of Hepatology|2024Cited by 0
Impact of pharmacological sGC stimulation with Riociguat in experimental models of liver disease regressionKatharina Bonitz, Philipp Schwabl, Philipp Königshofer et al.|Hepatology International|2026Cited by 0
Characterization of liver disease regression in murine models of liver fibrosis and portal hypertensionPhilipp Königshofer, Thomas Reiberger, Ksenia Brusilovskaya et al.|Scientific Reports|2026Cited by 0